Ocular and Orbital Infections in the Immunocompromised Cancer Patient

  • Viet H. HoEmail author
  • Hao H. Ho
Part of the M.D. Anderson Solid Tumor Oncology Series book series (MDA, volume 6)


Significant progress has been made in the treatment of cancer patients, and the proportion of cancer patients achieving complete remission and longer survival has increased in recent years. However, a significant proportion of patients still do not achieve complete remission, and infection remains a frequent cause of treatment failure, particularly in patients with hematologic malignancies. Ocular and orbital infections are particularly important, not only because of their frequency but also because of the associated local and systemic morbidity. Opportunistic infections can be found in all areas in and around the eye: in extraocular locations (neuro-ophthalmic, orbital, ocular adnexa), in the anterior segment (cornea and conjunctiva), and in the posterior segment (retina and choroid). All opportunistic infections of the eye have their origin in suppression of the host’s immune system. Immune suppression can be acquired as a result of immunosuppressive therapy in solid organ transplant recipients or chemotherapy in patients with myeloproliferative disorders or solid tumors. Neutropenia remains the most important factor predisposing patients to infections.


Chronic Lymphocytic Leukemia Herpes Zoster Varicella Zoster Virus Candida Species Orbital Cellulitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Marchetti O, Calandra T. Infections in the neutropenic cancer patient. In: Cohen J, Powderly WG, editors. Infectious Diseases, second edition. New York, NY: Mosby, 2004:1077–93.Google Scholar
  2. 2.
    Segal BH, Walsh TJ, Gea-Banacloche J, et al. Infections in the cancer patient. In: DeVita VT Jr, Hellman S, Rosenberg SA, editors. Cancer Principles and Practice of Oncology, seventh edition. Philadelphia, PA: Lippincott Williams & Wilkins, 2005:2461–2511.Google Scholar
  3. 3.
    Bannister B, Gillespie S, Jones J. Infections in immunocompromised patients. In: Infection Microbiology and Management. Oxford: Blackwell, 2006:431–42.Google Scholar
  4. 4.
    Rolston KV. Infection in the neutropenic patient. In: Kantarjuan HM, Wolff RA, Koller CA, editors. The M. D. Anderson Manual of Medical Oncology. New York, NY: McGraw-Hill, 2006:957–66.Google Scholar
  5. 5.
    Vento S, Cainelli F. Infections in patients with cancer undergoing chemotherapy: aetiology, prevention, and treatment. Lancet 2003;4:595–604.CrossRefGoogle Scholar
  6. 6.
    Easty DL. Infection in the compromised eye. Trans Am Ophthalmol Soc 1986;105:61–8.Google Scholar
  7. 7.
    Bal AM, Gould IM. Empirical antimicrobial treatment for chemotherapy-induced febrile neutropenia. Int J Antimicrob Agents 2007;29:501–9.PubMedCrossRefGoogle Scholar
  8. 8.
    Oken MM, Pomeroy C, Weisdorf D, et al. Prophylactic antibiotics for the prevention of early infection in multiple myeloma. Am J Med 1996;100:624–8.PubMedCrossRefGoogle Scholar
  9. 9.
    Noskin GA. Prevention of infection in immunocompromised hosts. In: Management of Infectious Complications in Cancer Patients. Boston: Kluwer, 1998:223–46.Google Scholar
  10. 10.
    Kowalski RP, Karenchak LM, Romanowski EG. Infectious disease: changing antibiotic susceptibility. Ophthalmol Clin North Am 2004;16:1–9.CrossRefGoogle Scholar
  11. 11.
    Bodey GP, Chamaly RF, Kontoyiannis DP. Fungal and viral infections in cancer patients. In: Kantarjuan HM, Wolff RA, Koller CA, editors. The M. D. Anderson Manual of Medical Oncology. New York, NY: McGraw-Hill, 2006:967–92.Google Scholar
  12. 12.
    Samonis G, Bafaloukos D. Fungal infections in cancer patients: an escalating problem. In Vivo 1992;6:183–94.PubMedGoogle Scholar
  13. 13.
    Powles RL. Systemic fungal infections: major problems in cancer patients. Indian J Cancer 1994;31:180–4.PubMedGoogle Scholar
  14. 14.
    Mays SR, Bogle MA, Bodey GP. Cutaneous fungal infections in the oncology patient. Am J Clin Dermatol 2006;7:31–43.PubMedCrossRefGoogle Scholar
  15. 15.
    Cornely OA, Bohme A, Reichert D, et al. Risk factors for breakthrough invasive fungal infection during secondary prophylaxis. J Antimicrob Chemother 2008;61:939–46.PubMedCrossRefGoogle Scholar
  16. 16.
    Anaissie E. Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review. Clin Infect Dis 1992;14:S43–53.PubMedCrossRefGoogle Scholar
  17. 17.
    Herbrecht R, Denning DW, Patterson TF. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002;347:408–15.PubMedCrossRefGoogle Scholar
  18. 18.
    Rolston KV, Bodey GP, Safdar A. Polymicrobial infection in patients with cancer: an underappreciated and underreported entity. Clin Infect Dis 2007;45:228–33.PubMedCrossRefGoogle Scholar
  19. 19.
    Jack MK, Hicks JD. Ocular complications in high-dose chemoradiotherapy and marrow transplantation. Ann Ophthalmol 1981;13:709–11.PubMedGoogle Scholar
  20. 20.
    Lynn WA, Lightman S. The eye in systemic infection. Lancet 2004;364:1439–50.PubMedCrossRefGoogle Scholar
  21. 21.
    Khan A, Okhravi N, Lightman S. The eye in systemic sepsis. Clin Med 2002;2:444–8.PubMedGoogle Scholar
  22. 22.
    Mahajan VM. Acute bacterial infections of the eye: their aetiology and treatment. Br J Ophthalmol 1983;67:191–4.PubMedCrossRefGoogle Scholar
  23. 23.
    Guembel HOC, Ohrloff C. Opportunistic infections of the eye in immunocompromised patients. Ophthalmologica 1997;211:53–61.PubMedCrossRefGoogle Scholar
  24. 24.
    Bialasiewicz AA, Knospe V, Richard G. Ocular infections in the immunocompromised host. Dev Ophthalmol 1999;30:203–19.CrossRefGoogle Scholar
  25. 25.
    Sridhar MS, Laibson PR, Rapuano CJ, et al. Infectious crystalline keratopathy in an immunosuppressed patient. CLAO J 2001;27:108–10.PubMedGoogle Scholar
  26. 26.
    Jain ML, Garg AK. Metastatic endophthalmitis in a patient with major burns: a rare complication. Burns 1995;21:72–3.PubMedCrossRefGoogle Scholar
  27. 27.
    Tabbara KF, Juffali F, Matossian RM. Bacillus laterosporus endophthalmitis. Arch Ophthalmol 1977;95:2187–9.CrossRefGoogle Scholar
  28. 28.
    Hornblass A, To K, Coden DJ, et al. Endogenous orbital cellulites and endogenous endophthalmitis in subacute bacterial endocarditis. Am J Ophthalmol 1989;108:196–7.PubMedGoogle Scholar
  29. 29.
    Li S, Perlman JI, Edward DP, et al. Unilateral blastomyces dermatitidis endophthalmitis and orbital cellulites. Ophthalmology 1998;105:1466–70.PubMedCrossRefGoogle Scholar
  30. 30.
    Maccheron LJ, Groeneveld ER, Ohlrich SJ, et al. Orbital cellulitis, panophthalmitis, and ecthyma gangrenosum in an immunocompromised host with Pseudomonas septicemia. Am J Ophthalmol 2004;137;176–8.PubMedCrossRefGoogle Scholar
  31. 31.
    Lakosha H, Pavlin CJ, Lipton J. Subretinal abscess due to Nocardia farcinica infection. Retina 2000;20:269–74.PubMedCrossRefGoogle Scholar
  32. 32.
    Tsai PS, DeAngelis DD, Spencer WH, et al. Bacillary angiomatosis of the anterior orbit, eyelid, and conjunctiva. Am J Ophthalmol 2002;134:433–4.PubMedCrossRefGoogle Scholar
  33. 33.
    Patel SJ, Petrarca R, Shah SM, et al. Atypical bartonella henselae chorioretinitis in an immunocompromised patient. Ocul Immunol Inflamm 2008;16:45–9.PubMedCrossRefGoogle Scholar
  34. 34.
    Koreishi AF, Schechter BA, Karp CL. Ocular infections caused by Providencia rettgeri. Ophthalmology 2006;113:1463–6.PubMedCrossRefGoogle Scholar
  35. 35.
    Hoerni B, Vallat M, Durand M, et al. Ocular toxoplasmosis and Hodgkin’s disease. Arch Ophthalmol 1978;96:62–3.PubMedCrossRefGoogle Scholar
  36. 36.
    Shah MK, Sebti A, Kiehn TE, et al. Mycobacterium haemophilum in immunocompromised patients. Clin Infect Dis 2001;33:330–7.PubMedCrossRefGoogle Scholar
  37. 37.
    Millar MJ, Bulliard C, Balachandran C, et al. Mycobacterium haemophilum infection presenting as filamentary keratopathy in an immunocompromised adult. Cornea 2007;26:764–6.PubMedCrossRefGoogle Scholar
  38. 38.
    Modi D, Pyatetsky D, Edward DP, et al. Mycobacterium haemophilum, a rare cause of endophthalmitis. Retina 2007;27:1148–51.PubMedCrossRefGoogle Scholar
  39. 39.
    Ali S, Sivak-Callcot JA, Khakoo R, et al. Mycobacterium fortuitum infection masquerading as an orbital mass. Ophthal Plast Reconstr Surg 2007;23:327–9.PubMedCrossRefGoogle Scholar
  40. 40.
    Bansal R, Tutrone WD, Weinberg JM. Viral skin infections in the elderly. Drugs Aging 2002;19:503–14.PubMedCrossRefGoogle Scholar
  41. 41.
    Khan BF, Pavan-Langston D. Clinical manifestations and treatment modalities in herpes simplex virus of the ocular anterior segment. Int Ophthalmol Clin 2004;44:103–33.PubMedCrossRefGoogle Scholar
  42. 42.
    Foster WJ, Krause MD, Custer PL. Herpes simplex virus dacryoadenitis in an immunocompromised patient. Arch Ophthalmol 2003;121:911–12.PubMedCrossRefGoogle Scholar
  43. 43.
    Lightman S, Marsh RJ, Powell D. Herpes zoster ophthalmicus: a medical review. Br J Ophthalmol 1981;65:539–41.PubMedCrossRefGoogle Scholar
  44. 44.
    Greven CM, Singh T, Stanton CA, et al. Optic chiasm, optic nerve, and retinal involvement secondary to varicella-zoster virus. Arch Ophthalmol 2001;119:608–10.PubMedCrossRefGoogle Scholar
  45. 45.
    Friedlander SM, Rahhal FM, Ericson L, et al. Optic neuropathy preceding acute retinal necrosis in acquired immunodeficiency syndrome. Arch Ophthalmol 1995;114:1481–5.CrossRefGoogle Scholar
  46. 46.
    Lee MS, Cooney EL, Stoessol KM, et al. Varicella zoster virus retrobulbar optic neuritis proceeding retinitis in patients with acquired immune deficiency syndrome. Ophthalmology 1998;105:467–71.PubMedCrossRefGoogle Scholar
  47. 47.
    Long HM, Dick A. Presumed CMV associated necrotizing retinopathy in a non-HIV immunocompromised host. Clin Exp Ophthalmol 2005;33:330–5.CrossRefGoogle Scholar
  48. 48.
    Foster RE, Peterson MR, Neuss MN, et al. Progressive outer retinal necrosis syndrome in a lymphoma patient with good visual outcome. Am J Ophthalmol 2001;132:117–20.PubMedCrossRefGoogle Scholar
  49. 49.
    Kalpoe JS, van Dehn CE, Bollemeijer JG, et al. Varicella zoster virus (VZV)-related progressive outer retinal necrosis (PORN) after allogeneic stem cell transplantation. Bone Marrow Transplant 2005;36:467–9.PubMedCrossRefGoogle Scholar
  50. 50.
    Westeneng AC, Rothova A, De Boer JH, et al. Infectious uveitis in immunocompromised patients and the diagnostic value of polymerase chain reaction and Goldmann-Witmer coefficient in aqueous analysis. Am J Ophthalmol 2007;144:781–5.PubMedCrossRefGoogle Scholar
  51. 51.
    Akpek EK, Kent C, Jakobiec F, et al. Bilateral acute retinal necrosis caused by cytomegalovirus in an immunocompromised patient. Am J Ophthalmol 1999;127:93–5.PubMedCrossRefGoogle Scholar
  52. 52.
    Derzko-Dzulynsky LA, Berger AR, Berinstein NL. Cytomegalovirus retinitis and low-grade non-Hodgkin’s lymphoma: case report and review of the literature. Am J Hematol 1998;57:228–32.PubMedCrossRefGoogle Scholar
  53. 53.
    Duker JS, Blumenkranz MS. Diagnosis and management of the acute retinal necrosis syndrome (ARN). Surv Ophthalmol 1995;35:327–43.CrossRefGoogle Scholar
  54. 54.
    Pollard RB, Egbert PR, Gallagher JG, et al. Cytomegalovirus retinitis in immunosuppressed hosts. I. Natural history and effects of treatment with adenine arabinoside. Ann Intern Med 1980;93:655–64.PubMedGoogle Scholar
  55. 55.
    Egbert PR, Pollard RB, Gallagher JG, et al. Cytomegalovirus retinitis in immunosuppressed hosts. II. Ocular manifestation. Ann Intern Med 1980;93:664–70.PubMedGoogle Scholar
  56. 56.
    Segal BH, Almyroudis NG, Battiwalla M, et al. Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts. Clin Infect Dis 2007;44:402–9.PubMedCrossRefGoogle Scholar
  57. 57.
    Thursky KA, Playford EG, Seymour JF, et al. Recommendations for the treatment of established fungal infections. Intern Med J 2008;38:496–520.PubMedCrossRefGoogle Scholar
  58. 58.
    Hariprasad SM, Mieler WF, Lin TK, et al. Voriconazole in the treatment of fungal eye infections: a review of current literature. Br J Ophthalmol 2008;92:871–8.PubMedCrossRefGoogle Scholar
  59. 59.
    de O Machado O, Goncalves R, Fernandes EM, et al. Bilateral aspergillus endophthalmitis in a patient with chronic lymphocytic leukaemia. Br J Ophthalmol 2003;87:1429–30.CrossRefGoogle Scholar
  60. 60.
    Hilal AA, Taj-Aldeen SJ, Mirghani AH. Rhinoorbital mucormycosis secondary to Rhizopus oryzae: a case report and literature review. Ear Nose Throat J 2004;83:556–62.PubMedGoogle Scholar
  61. 61.
    Jeevanan J, Gendeh BS, Faridah HA, et al. Rhino-orbito-cerebral mucormycosis: a treatment dilemma. Med J Malaysia 2006;61:106–8.PubMedGoogle Scholar
  62. 62.
    Louie T, el Baba F, Shulman M, et al. Endogenous endophthalmitis due to fusarium: case report and review. Clin Infect Dis 1994;18:585–8.PubMedCrossRefGoogle Scholar
  63. 63.
    O’Doherty M, Hannan M, Fulcher T. Voriconazole in the treatment of fungal osteomyelitis of the orbit in the immunocompromised host. Orbit 2005;24:285–9.PubMedCrossRefGoogle Scholar
  64. 64.
    Wood GM, McCormack JG, Muir DB, et al. Clinical features of human infection with Scedosporium inflatum. Clin Infect Dis 1992;14:1027–33.PubMedCrossRefGoogle Scholar
  65. 65.
    Gluckman SJ, Ries K, Abrutyn E. Allescheria (Petriellidium) boydii sinusitis in a compromised host. J Clin Microbiol 1977;5:481–4.PubMedGoogle Scholar
  66. 66.
    Anderson RL, Carroll TF, Harvey JT. Petriellidium (Allescheria) boydii orbital and brain abscess treated with intravenous miconazole. Am J Ophthalmol 1984;97:771–5.PubMedGoogle Scholar
  67. 67.
    Jones J, Katz SE, Lubow M. Scedosporium apiospermum of the orbit. Arch Ophthalmol 1999;117:27203.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Danville San Ramon Eye Medical Corp.DanvilleUSA
  2. 2.Jefferson Medical CollegePhiladelphiaUSA

Personalised recommendations